Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-46.51	-7.27	-3.39	-3.46	-5.16
Depreciation & Amortization	1.06	0.29	0.19	0.19	0.19
Share-Based Compensation	3.74	1.09	0.39	0.5	0.42
Other Operating Activities	4.8	-1.82	-0.03	-0.88	-0.51
Operating Cash Flow	-36.91	-7.71	-2.84	-3.64	-5.05
Capital Expenditures	-1.07	-0.27	-0.38	-0.27	-0.41
Acquisitions	2.7	0	0	0	0
Change in Investments	22.76	0	0	0	0.83
Other Investing Activities	-0.02	-0.02	-0.03	-0.01	-0.01
Investing Cash Flow	24.37	-0.28	-0.41	-0.29	0.4
Share Issuance / Repurchase	0.85	0.06	64.69	1.01	7.39
Debt Issued / Paid	-0.07	0	0	0	0
Other Financing Activities	-	-	-0.01	-0.01	-0.01
Financing Cash Flow	0.79	0.06	64.68	0.99	7.37
Net Cash Flow	-11.76	-7.94	61.44	-2.93	2.73
Free Cash Flow	-37.99	-7.98	-3.22	-3.91	-5.46
Free Cash Flow Margin	-2648.88%	-	-32.00%	-40.43%	-74.64%
Free Cash Flow Per Share	-1.42	-0.56	-0.31	-0.58	-0.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).